New biologic injection takes on steroids for rotator cuff pain — but study pulled
NCT ID NCT06712290
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study aimed to compare a single injection of connective tissue matrix (CTM) against a standard corticosteroid shot for treating rotator cuff tendinopathy. Participants would have been randomly assigned to one of the two injections and followed for six months with questionnaires and physical tests. However, the study was withdrawn before enrolling any patients, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Connective tissue matrix (CTM) injection
What this could lead to
If it works, this could offer a biologic alternative to steroid injections for shoulder pain, potentially with fewer side effects.
What could go wrong
This trial was withdrawn before enrolling any participants, so no results exist. The approach is very early and unproven.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegheny Health Network Federal North Medical Office Building
Pittsburgh, Pennsylvania, 15212, United States